GEMINI THERAPEUTICS INC (GMTX)

US36870G1058 - Common Stock

1.35  0 (0%)

After market: 1.32 -0.03 (-2.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2022-9-30)		 2021
(2021-12-31)		 2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-43.42M-71.87M-810.00K
Depreciation Amortization
46.00K231.00KN/A
Change In Working Capital
-5.86M1.86M400.00K
Interest Paid
177.00K307.00KN/A
Other non cash items
6.72M10.08M0.00
OPERATING CASH FLOW
-42.52M-59.70M-420.00K
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/A-71.00KN/A
Other Investing Activity
N/A415.00K-120.75M
INVESTING CASH FLOW
N/A344.00K-120.75M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
-6.67M-4.58M0.00
Stock Issued/Repurchased
122.00K181.00K125.19M
Other Financing Activity
0.00195.88M-2.81M
FINANCING CASH FLOW
-6.54M191.48M122.38M
 
CHANGE IN CASH
-48.66M132.12M1.21M
 
FREE CASH FLOW
Operating Cash Flow
-42.52M-59.70M-420.00K
Capital Expenditure
N/A-71.00KN/A
FREE CASH FLOW
-42.52M-59.77M-420.00K

All data in USD

Charts